TAU
2-AMINOETHANESULFONIC ACID
Find entries where: TAU
is present as a standalone ligand in 24 entries
as a non-polymer is covalently linked to polymer or other heterogen groups 1 entries
Chemical Component Summary | |
---|---|
Name | 2-AMINOETHANESULFONIC ACID |
Identifiers | 2-aminoethanesulfonic acid |
Formula | C2 H7 N O3 S |
Molecular Weight | 125.147 |
Type | NON-POLYMER |
Isomeric SMILES | C(CS(=O)(=O)O)N |
InChI | InChI=1S/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6) |
InChIKey | XOAAWQZATWQOTB-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 14 |
Chiral Atom Count | 0 |
Bond Count | 13 |
Aromatic Bond Count | 0 |
Drug Info: DrugBank
DrugBank ID | DB01956 |
---|---|
Name | Taurine |
Groups |
|
Description | Taurine, whose chemical name is 2-aminoethanesulfonic acid, is one of the most abundant amino acids in several organs. It plays important role in essential biological processes.[A31396] This conditional amino acid can be either be manufactured by the body or obtained in the diet mainly by the consumption of fish and meat.[L1058] The supplements containing taurine were FDA approved by 1984 and they are hypertonic injections composed by cristalline amino acids.[FDA label] |
Synonyms |
|
Brand Names |
|
Indication | The use of diet supplements containing taurine is indicated for the nutritional support of infants and young pediatric patients requiring total parenteral nutrition via central or peripheral routes. The usage of diet supplements containing taurine prevents nitrogen and weight loss or to treat negative nitrogen balance in pediatric patients where the alimentary tract cannot be done through oral, gastrostomy or jejunostomy administration, there is impaired gastrointestinal absorption or protein requirements are substantially increased.[FDA label] |
Categories |
|
CAS number | 107-35-7 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Glutamate receptor ionotropic, NMDA 2B | MKPRAECCSPKFWLVLAVLAVSGSRARSQKSPPSIGIAVILVGTSDEVAI... | unknown | inhibitor |
Glycine receptor subunit alpha-2 | MNRQLVNILTALFAFFLETNHFRTAFCKDHDSRSGKQPSQTLSPSDFLDK... | unknown | agonist |
Glycine receptor subunit alpha-3 | MAHVRHFRTLVSGFYFWEAALLLSLVATKETDSARSRSAPMSPSDFLDKL... | unknown | agonist |
GABA(A) Receptor | MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRILDRLL... | unknown | agonist |
Gamma-aminobutyric acid type B receptor subunit 1 | MLLLLLLAPLFLRPPGAGGAQTPNATSEGCQIIHPPWEGGIRYRGLTRDQ... | unknown | agonist |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 4068592, 1123 |
ChEMBL | CHEMBL239243 |
ChEBI | CHEBI:15891, CHEBI:507393 |
CCDC/CSD | ODIDUC |